88
Views
16
CrossRef citations to date
0
Altmetric
Original Article

T-Large Granular Lymphocyte Leukemia Accompanied by an Increase of Natural Killer Cells (CD3-) and Associated with Ulcerative Colitis and Autoimmune Hepatitis

, &
Pages 207-212 | Published online: 01 Jul 2009

References

  • Loughran T. P., Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82: 1–14
  • Kondo H., Narita K., Watanabe J., Iwasaki H. Effectiveness of cyclosporine A in a patient with pure red cell aplasia associated with T cell-lineage granular lymphocyte proliferative disorders resistant to cyclophosphamide therapy. Eur J Haematol 2000; 64: 206–207
  • Kondo H., Uematsu M., Watanabe J., Takahashi Y., Hayashi K., Iwasaki H. CD3+,CD4-,CD8-, TCRα β-, TCRγ δ + granular lymphocyte proliferative disorders without lymphocytosis and clinical symptoms. Acta haematol
  • Tefferi A., Li C. -Y., Witzig T. E., Dhodapkar M. V., Okuno S. H., Phyliky R. L. Chronic natural killer cell lymphocytosis: A descriptive study. Blood 1994; 84: 2721–2725
  • Okuno S. H., Tefferi A., Hanson C. A., Katzman J. A., Li C. -Y. Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells. Br J Haematol 1996; 93: 810–812
  • Rabbani G. R., Phyliky R. L., Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol 1999; 106: 960–966
  • Scott C. S., Richards S. J., Sivakumaran M., Short M., Child J. A., Hunt K. M., McEvoy M., Steed A. J., Balfour I. C., Parapia L. A., McVerry B. A., Bynoe A. G., Galvin M. C., Norfolk D. R., Roberts B. E. Transient and persistent expansions of large granular lymphocytes(LGL) and NK-associated(NKa) cells: the Yorkshire Leukaemia Group Study. Br J Haematol 1993; 83: 505–515
  • Cantoni C., DeTotero D., Lauria F., Raspadori D., Conte R., Ferrini S., Tazzari P. L., Biassoni R. Phenotypic, functional and molecular analysis of CD3−LGL expansions indicates a relationship to two different CD3−normal counterparts. Br J Haematol 1994; 86: 740–745
  • Tomita N., Motomura S., Takemura S., Fujimaki K., Sakai R., Harano H., Ishigatusbo Y. CD16+ CD56− indolent NK cell-lineage granular lymphocyte proliferative disorder with autoimmune hemolytic anemia. Rinsho Ketsueki 2000; 41: 225–228
  • Chan W. C., Gu L. B., Masih A., Nicholson J., Vogler W. R., Yu G., Nasr A. Large granular lymphocyte proliferation with natural killer-cell phenotype. Hematopathol 1992; 97: 353–358
  • Perdigoto R., Carpenter H. A., Czaja A. J. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol 1992; 14: 325–331
  • Giacomelli R., Passsacantando A., Frieri G., Parzanese I., D'alo S., Vernia P., Pimpo M. T., Petrucci R., Caprilli R., Cifone M. G., Tonieetti G. Circulating soluble factor-inhibiting natural killer(NK) activity of fresh peripheral blood mononuclear cells(PBMC) from inflammatory bowel disease(IBD) patients. Clin Exp Immunol 1999; 115: 72–77
  • Egawa S., Hiwatashi N. Natural killer cell activity in patients with inflammatory bowel disease. J Clin Lab Immunol 1986; 20: 187–192
  • Johnson P. J., McFarlane I. O. G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998–1005
  • Borgonovo G., Secondo V., Varaldo E., Pistoia V., Gobbi M., Mattioli F. P. Large granular lymphocyte leukemia associated with hepatocellular carcinoma: A case report. Haematolgica 1996; 81: 172–174

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.